Connection

Xiaokun Li to Dipeptidyl-Peptidase IV Inhibitors

This is a "connection" page, showing publications Xiaokun Li has written about Dipeptidyl-Peptidase IV Inhibitors.
  1. FGF21 and DPP-4 inhibitor equally prevents cognitive decline in obese rats. Biomed Pharmacother. 2018 Jan; 97:1663-1672.
    View in: PubMed
    Score: 0.120
  2. Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase-4 inhibitor in prediabetic rats. Cardiovasc Ther. 2017 Aug; 35(4).
    View in: PubMed
    Score: 0.117
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.